Schapiro, R T <br/><br/>
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.  [electronic resource] 

 -  Current neurology and neuroscience reports  May 2001 
 - 299-302 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1528-4042 
<br/><br/><label>Standard No.: </label>10.1007/s11910-001-0034-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--therapeutic use<br/>Amines<br/>Autoimmune Diseases--complications<br/>Baclofen--administration & dosage<br/>Benzodiazepines--therapeutic use<br/>Botulinum Toxins, Type A--therapeutic use<br/>Cannabinoids--therapeutic use<br/>Causalgia--drug therapy<br/>Clonidine--analogs & derivatives<br/>Cyclohexanecarboxylic Acids<br/>Dantrolene--therapeutic use<br/>Dystonia--drug therapy<br/>GABA Agonists--therapeutic use<br/>Gabapentin<br/>Humans<br/>Mechanoreceptors--physiology<br/>Multiple Sclerosis--complications<br/>Muscle Relaxants, Central--therapeutic use<br/>Muscle Spasticity--drug therapy<br/>Pain--drug therapy<br/>Physical Therapy Modalities<br/>Receptors, GABA-A--drug effects<br/>Receptors, GABA-B--drug effects<br/>Relaxation Therapy<br/>Trigeminal Neuralgia--drug therapy<br/>gamma-Aminobutyric Acid